Protelica, a U.S. biotechnology company, has licensed its library of billions of pronectines, nanoantibodies, and a portfolio of 12 patents to the foundation. As part of the partnership, the Renato Dulbecco Foundation will leverage the Dante platform to identify nanoantibodies and their efficacy for a wide range of applications. Additional R&D activities will be outsourced to Twist Biosciences.

The Renato Dulbecco Foundation was selected to receive government funds of approximately $30 million and will employ at least 100 people, including researchers, collaborators, and employees.

Dante Labs is a global genomic data company building and commercializing a new class of health and longevity applications based on whole-genome sequencing and artificial intelligence.

Financial details of the collaboration were not disclosed.

Twist Bioscience, Eleven Therapeutics create replicon for antiviral development
Twist Bioscience and Eleven Therapeutics have created a replicon tool that could be used for studying viral genome replication and antiviral drug screening...

Twist Bioscience partners with Artisan Bio on next-gen cell therapies
Twist Bioscience and Artisan Bio have entered into a collaboration agreement to discover novel antibodies against five undisclosed targets, with an option...

Twist Bioscience develops innovative enzymatic DNA synthesis process
Twist Bioscience has developed an innovative, low-cost, scarless, and scalable enzymatic DNA synthesis process. With these comprehensive capabilities...

Twist Bioscience launches 96-plex library prep kit
Twist Bioscience has released the Twist 96-Plex Library Prep Kit, a high-performance, cost-effective preparation kit for next-generation sequencing.